Downside risk for Sonic Healthcare
Sonic Healthcare (ASX:SHL) shares have endured a challenging 24 months. The main reason is that the contribution from high-margin COVID PCR testing has been all but eroded. We recently researched SHL in The Dynamic Investor after the Company released results for the six months to 31 December 2023 (1H24). Are the shares nearing a bottom? Or are there still red flags to keep investors on the sidelines? About Sonic Healthcare Sonic Healthcare (SHL) provides highly specialised pathology/clinical laboratory and diagnostic …